2024
Clinical neurophysiology in the treatment of movement disorders: IFCN handbook chapter
Lefaucheur J, Moro E, Shirota Y, Ugawa Y, Grippe T, Chen R, Benninger D, Jabbari B, Attaripour S, Hallett M, Paulus W. Clinical neurophysiology in the treatment of movement disorders: IFCN handbook chapter. Clinical Neurophysiology 2024, 164: 57-99. PMID: 38852434, PMCID: PMC11418354, DOI: 10.1016/j.clinph.2024.05.007.Peer-Reviewed Original ResearchTranscranial alternating current stimulationTranscranial direct current stimulationLow-intensity transcranial electrical stimulationRepetitive transcranial magnetic stimulationSpinal cord stimulationCurrent stimulationMovement disordersTreated with botulinum toxin injectionsPulse generatorTranscranial electrical stimulationBotulinum toxin injectionIdentification of musclesShort-term clinical impactDirect current stimulationDeep brain stimulationAt-home useTherapeutic neuromodulationChronic diseasesTranscranial applicationTranscranial magnetic stimulationSurgical implantation of electrodesTreatment of movement disordersFUS stimulationAxial signsNeuromodulation techniques
2018
Botulinum Toxin in Restless Legs Syndrome—A Randomized Double-Blind Placebo-Controlled Crossover Study
Mittal SO, Machado D, Richardson D, Dubey D, Jabbari B. Botulinum Toxin in Restless Legs Syndrome—A Randomized Double-Blind Placebo-Controlled Crossover Study. Toxins 2018, 10: 401. PMID: 30274305, PMCID: PMC6215171, DOI: 10.3390/toxins10100401.Peer-Reviewed Original ResearchConceptsRestless legs syndromePain scoresCrossover studyLegs syndromePlacebo-controlled crossover studyDouble-blind placeboPatient Global ImpressionVisual analog scalePrevious smaller studiesCommon movement disorderQuality of lifeIncobotulinumtoxin APlacebo groupRLS symptomsAnalog scaleGlobal ImpressionOnabotulinumtoxin ALife QuestionnaireTibialis anteriorBotulinum toxinNormal salineMovement disordersRLS scoresSmall studyFemoris muscleBotulinum Toxin Treatment of Movement Disorders
Safarpour Y, Jabbari B. Botulinum Toxin Treatment of Movement Disorders. Current Treatment Options In Neurology 2018, 20: 4. PMID: 29478149, DOI: 10.1007/s11940-018-0488-3.Peer-Reviewed Original ResearchTask-specific dystoniaMovement disordersHemifacial spasmBotulinum toxin treatmentMovement disorder expertsHigh-quality studiesAutonomic dysfunctionOromandibular dystoniaCervical dystoniaPain disordersBoNT therapyRest tremorLaryngeal dystoniaVocal ticsToxin treatmentTourette syndromeDystoniaDisorder expertsEssential tremorAmerican AcademyTherapeutic agentsFirst choiceEfficacyDisordersBlepharospasm
2017
The nature, consequences, and management of neurological disorders in chronic kidney disease
Jabbari B, Vaziri ND. The nature, consequences, and management of neurological disorders in chronic kidney disease. Hemodialysis International 2017, 22: 150-160. PMID: 28799704, DOI: 10.1111/hdi.12587.Peer-Reviewed Original ResearchConceptsChronic kidney diseaseNeurological disordersNeurological symptomsKidney diseaseImpaired blood-brain barrierDiffuse white matter diseasePeripheral neurological symptomsRestless legs syndromeCentral neurological symptomsBlood-brain barrierWhite matter diseaseCentral nervous systemReflex myoclonusNeurological complicationsPeripheral neuropathyBrain edemaCortical myoclonusHemodynamic disordersLegs syndromePeripheral originBasal gangliaBrain barrierSubcortical lesionsMovement disordersSubcortical pathology
2016
History of Botulinum Toxin Treatment in Movement Disorders
Jabbari B. History of Botulinum Toxin Treatment in Movement Disorders. Tremor And Other Hyperkinetic Movements 2016, 6: 394. PMID: 27917308, PMCID: PMC5133258, DOI: 10.5334/tohm.321.Peer-Reviewed Original Research
2015
Arm Posturing in a Patient Following Stroke: Dystonia, Levitation, Synkinesis, or Spasticity?
Irmady K, Jabbari B, Louis ED. Arm Posturing in a Patient Following Stroke: Dystonia, Levitation, Synkinesis, or Spasticity? Tremor And Other Hyperkinetic Movements 2015, 5: 353. PMID: 26682091, PMCID: PMC4681881, DOI: 10.7916/d8222tbh.Peer-Reviewed Original ResearchPost-stroke movement disordersArm contralateralArm posturingInvoluntary elevationIschemic strokeStroke patientsFollowing StrokeMovement disordersAppropriate treatmentDifferential diagnosisClinical phenomenologyDiagnostic possibilitiesSpasticitySynkinesisArm levitationDystoniaStrokeUnusual movementsPatientsContralateralDiagnosis
2013
Primary dystonias and genetic disorders with dystonia as clinical feature of the disease
Moghimi N, Jabbari B, Szekely AM. Primary dystonias and genetic disorders with dystonia as clinical feature of the disease. European Journal Of Paediatric Neurology 2013, 18: 79-105. PMID: 23911094, DOI: 10.1016/j.ejpn.2013.05.015.Peer-Reviewed Original ResearchConceptsPrimary dystoniaClinical featuresSustained muscle contractionsCharacteristic clinical featuresClinical entityAbnormal postureMovement disordersDystoniaClinical practiceClinical phenomenologyAdvances of geneticsGenetic syndromesMuscle contractionRepetitive movementsUnderlining etiologiesDisordersCommon formMonogenic disordersGenetic disordersMolecular underpinningsDetailed searchMendelian disordersComplex casesLarge groupSyndrome
2012
Orofacial Dyskinesia After Moxifloxacin Treatment—A Case With Normal Hepatorenal Function and Review of Literature
Mittal SO, Machado DG, Jabbari B. Orofacial Dyskinesia After Moxifloxacin Treatment—A Case With Normal Hepatorenal Function and Review of Literature. Clinical Neuropharmacology 2012, 35: 292-294. PMID: 23151468, DOI: 10.1097/wnf.0b013e31826ba0eb.Peer-Reviewed Original ResearchConceptsOrofacial dyskinesiaReview of literatureThird-generation fluoroquinoloneFourth-generation fluoroquinolone moxifloxacinFourth-generation fluoroquinolonesAcute bronchitisKidney functionFirst patientHepatorenal functionLiver functionMovement disordersInvoluntary movementsDyskinesiaFluoroquinolone moxifloxacinPatientsMoxifloxacinFacial musclesFluoroquinolonesAntibioticsSignificant reductionTreatmentFluoroquinolone antibioticsClonidineDiscontinuationBronchitis